Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression
Xiangpeng Tan(First Affiliated Hospital of Jinan University), Bin Li(First Affiliated Hospital of Henan University)
Cited by 62
Related Papers
Targeting PI3K/Akt signal transduction for cancer therapy
|Signal Transduction and Targeted Therapy|2021|1.7k
Advances in targeted therapy for esophageal cancer
|Signal Transduction and Targeted Therapy|2020|546
Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment
|MedComm|2021|369